Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
The Journal of Molecular Diagnostics : JMD
|
August 4, 2020
Analysis of Driver Mutational Hot Spots in Blood-Derived Cell-Free DNA of Patients with Primary Central Nervous System Lymphoma Obtained before Intracerebral Biopsy
Manuel Montesinos-Rongen, Anna Brunn, Armin Tuchscherer, et al.
Journal of Neurology
|
June 6, 2023
Morphological and molecular comparison of HIV-associated and sporadic inclusion body myositis
Sinja Vogt, Felix Kleefeld, Corinna Preusse, et al.
Acta Neuropathologica
|
September 29, 2023
Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis
Christopher Nelke, Christina B Schroeter, Lukas Theissen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 26, 2023
Diagnostic Accuracy of MR Spectroscopic Imaging and <sup>18</sup>F-FET PET for Identifying Glioma: A Biopsy-Controlled Hybrid PET/MRI Study
Jörg Mauler, Philipp Lohmann, Andrew A Maudsley, et al.
Neuro-Oncology
|
December 22, 2021
Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases
Anna-Katharina Meißner, Robin Gutsche, Norbert Galldiks, et al.
Journal of Neuropathology and Experimental Neurology
|
March 16, 2007
Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression
Cornelius Courts, Manuel Montesinos-Rongen, Jose Ignacio Martin-Subero, et al.
Clinical Nuclear Medicine
|
January 14, 2025
The Value of Multidisciplinary Neuro-oncological Tumor Boards to Increase the Accuracy of FET PET for Identifying Brain Tumor Relapse
Garry S Ceccon, Jan-Michael Werner, Maximilian I Ruge, et al.
Nature Medicine
|
February 19, 2026
Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases
Christina Düsing, Andrea-Hermina Györfi, Ayla Nadja Stütz, et al.
Blood Cancer Discovery
|
January 15, 2021
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities
Ruth Flümann, Tim Rehkämper, Pascal Nieper, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
The Journal of Molecular Diagnostics : JMD
|
August 4, 2020
Analysis of Driver Mutational Hot Spots in Blood-Derived Cell-Free DNA of Patients with Primary Central Nervous System Lymphoma Obtained before Intracerebral Biopsy
Manuel Montesinos-Rongen, Anna Brunn, Armin Tuchscherer, et al.
Journal of Neurology
|
June 6, 2023
Morphological and molecular comparison of HIV-associated and sporadic inclusion body myositis
Sinja Vogt, Felix Kleefeld, Corinna Preusse, et al.
Acta Neuropathologica
|
September 29, 2023
Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis
Christopher Nelke, Christina B Schroeter, Lukas Theissen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 26, 2023
Diagnostic Accuracy of MR Spectroscopic Imaging and <sup>18</sup>F-FET PET for Identifying Glioma: A Biopsy-Controlled Hybrid PET/MRI Study
Jörg Mauler, Philipp Lohmann, Andrew A Maudsley, et al.
Neuro-Oncology
|
December 22, 2021
Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases
Anna-Katharina Meißner, Robin Gutsche, Norbert Galldiks, et al.
Journal of Neuropathology and Experimental Neurology
|
March 16, 2007
Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression
Cornelius Courts, Manuel Montesinos-Rongen, Jose Ignacio Martin-Subero, et al.
Clinical Nuclear Medicine
|
January 14, 2025
The Value of Multidisciplinary Neuro-oncological Tumor Boards to Increase the Accuracy of FET PET for Identifying Brain Tumor Relapse
Garry S Ceccon, Jan-Michael Werner, Maximilian I Ruge, et al.
Nature Medicine
|
February 19, 2026
Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases
Christina Düsing, Andrea-Hermina Györfi, Ayla Nadja Stütz, et al.
Blood Cancer Discovery
|
January 15, 2021
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities
Ruth Flümann, Tim Rehkämper, Pascal Nieper, et al.
Page
of 7